Biotech and Pharma

Stock Market

6 Defensive Healthcare Stocks for 2023

[ad_1] As investors face another uncertain year for public equities, large-cap healthcare stocks remain an attractive defensive play. They offer…

Read More »
Stock Market

Moderna Stock Is Upgraded on Growth Opportunities Not Related to Covid

[ad_1] Moderna was rising Monday after an analyst at Jefferies upgraded the stock citing confidence in the vaccine maker’s growth…

Read More »
Stock Market

Moderna Soared on Good News About Cancer Vaccine. Why the Stock Was Downgraded.

[ad_1] Moderna stock jumped by double digits Tuesday on positive news about the company’s cancer vaccine, but Chardan Capital Markets…

Read More »
Stock Market

Mirati, Boeing, Eli Lilly, Moderna, and More Market Movers

[ad_1] This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients…

Read More »
Stock Market

Buy AbbVie Stock. The Pharma Giant Is Still Worth Owning Even as Humira Fades.

[ad_1] Sometimes, a single worry grows so large that it obscures all the good things happening at the same time.…

Read More »
Stock Market

Novavax Stock Slides on Steep Cut to Sales Forecast

[ad_1] Text size Novavax slashed its revenue guidance for 2022. Karen Ducey/Getty Images Novavax slumped more than 30% early Tuesday…

Read More »
Stock Market

GSK to Buy U.S. Biotech Affinivax in $3.3 Billion Deal

[ad_1] Text size GSK is seeking to bolster its vaccine pipeline. AFP via Getty Images GSK said Tuesday it will…

Read More »
Stock Market

BioNTech Earnings Top Forecasts on Strong Sales of Covid-19 Vaccine

[ad_1] Text size The BioNTech logo on the facade of its manufacturing site in Marburg, central Germany. (Photo by THOMAS…

Read More »
Stock Market

Giant Pension Bought Tesla, Pfizer, and Starbucks Stock. It Sold Nike.

[ad_1] Text size Tesla Model 3 cars Jade Gao / AFP via Getty Images One of the largest U.S. public…

Read More »
Back to top button
Close